Fluorescent multivalent opsonophagocytic assay for measurement of functional antibodies to Streptococcus pneumoniae

Clinical and Diagnostic Laboratory Immunology

Volumn 12, Issue 10, 2005, Pages 1238-1242

  Bieging, Kathryn T ^a   Rajam, Gowrisankar ^a   Holder, Patricia ^a   Udoff, Ross ^a   Carlone, George M ^a   Romero Steiner, Sandra ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALAMAR BLUE; ANTIBODY; FLUORESCENT DYE; PNEUMOCOCCUS VACCINE; RIFAMPICIN; TRIMETHOPRIM; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; BACTERIAL SURVIVAL; CELL STRAIN HL 60; COLONY FORMING UNIT; CONTROLLED STUDY; FLUORESCENCE; HAEMOPHILUS INFLUENZAE; HUMAN; HUMAN CELL; INCUBATION TIME; NEISSERIA MENINGITIDIS; OPSONIZATION; PHAGOCYTOSIS; PRIORITY JOURNAL; SEROTYPE; SERUM BACTERICIDAL ACTIVITY; SIGNAL NOISE RATIO; STATISTICAL ANALYSIS; STREPTOCOCCUS PNEUMONIAE;

ANTIBODIES, BACTERIAL; COLONY COUNT, MICROBIAL; HUMANS; OPSONIN PROTEINS; OXAZINES; PHAGOCYTOSIS; PNEUMOCOCCAL INFECTIONS; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; XANTHENES;

EID: 26944441984     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.12.10.1238-1242.2005     Document Type: Article

References (20)

1. Black, S. B., H. R. Shinefield, S. Ling, J. Hansen, B. Fireman, D. Spring, J. Noyes, E. Lewis, P. Ray, J. Lee, and J. Hackell. 2002. Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia. Pediatr. Infect. Dis. J. 21:810-815.
2. Bogaert, D., M. Sluijter, R. de Groot, and P. W. M. Hermans. 2004. Multiplex opsonophagocytosis assay (MOPA): a useful tool for the monitoring of the 7-valent pneumococcal conjugate vaccine. Vaccine 22:4014-4020.
3. Capeding, M. Z. R., T. Puumalainen, C. P. Gepanayao, H. Käyhty, M. G. Lucero, and H. Nohynek. 10 August 2003, posting date. Safety and immunogenicity of three doses of an eleven-valent diphtheria toxoid and tetanus protein-conjugated pneumococcal vaccine in Filipino infants. BMC Infect. Dis. 3:17. [Online.] http://www.biomedcentral.com/1471-2334/3/17.
4. Cutts, F. T., S. M. A. Zaman, G. Enwere, S. Jaffar, O. S. Levine, J. B. Okoko, C. Oluwalana, A. Vaughan, S. K. Obaro, A. Leach, K. P. McAdam, E. Biney, M. Saaka, U. Onwuchekwa, F. Yallop, N. F. Pierce, B. M. Greenwood, and R. A. Adegbola. 2005. Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomized, double-blind, placebo-controlled trial. Lancet 365:1139-1146.
5. Flannery, B., S. Schrang, N. M. Bennett, R. Lynfield, L. H. Harrison, A. Reingold, P. R. Cieslak, J. Hadler, M. M. Farley, R. R. Facklam, E. R. Zell, and C. G. Whitney. 2004. Impact of childhood vaccination on racial disparities in invasive Streptococcus pneumoniae infections. JAMA 291:2197-2203.
6. Fleck, R. A., S. Romero-Steiner, and M. H. Nahm. 2005. Use of HL-60 cell line to measure opsonic capacity of pneumococcal antibodies. Clin. Diagn. Lab. Immunol. 12:19-27.
7. Hu, B. T., X. Yu, T. R. Jones, C. Kirch, S. Harris, S. W. Hildreth, D. V. Madore, and S. A. Quataert. 2004. Approach to validating an opsonophagocytic assay for Streptococcus pneumoniae. Clin. Diagn. Lab. Immunol. 12:287-295.
8. Huebner, R. E., N. Mbelle, B. Forrest, D. V. Madore, and K. Klugman. 2004. Long-term antibody levels and booster responses in South African children immunized with nonavalent pneumococcal conjugate vaccine. Vaccine 22:2696-2700.
9. Jódar, L., J. Butler, G. Carlone, R. Dagan, D. Goldblatt, H. Käyhty, K. Klugman, B. Plikaytis, G. Siber, R. Kohberger, I. Chang, and T. Cherian. 2003. Serological criteria for evaluations and licensure of new pneumococcal conjugate vaccine formulations for use in infants. Vaccine 21:3265-3272.
10. Johnson, S. E., L. Rubin, S. Romero-Steiner, J. K. Dykes, L. B. Pais, A. Rizvi, E. Ades, and G. M. Carlone. 1999. Correlation of opsonophagocytosis and passive protection assays using human anticapsular antibodies in an infant mouse model of bacteremia for Streptococcus pneumoniae. J. Infect. Dis. 180:133-140.
11. Kilpi, T., H. Åhman, J. Jokinen, K. S. Lankinen, A. Palmu, H. Savolainen, M. Grönholm, M. Leinenen, T. Hovi, J. Eskola, H. Käyhty, N. Bohidar, J. C. Sadoff, and P. H. Mäkelä. 2003. Protective efficacy of a second pneumococcal conjugate vaccine against pneumococcal acute otitis media in infants and children: randomized, controlled trial of a 7-valent pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine in 1666 children. Clin. Infect. Dis. 37:1155-1164.
12. Kim, K. H., J. U. Yu, and M. H. Nahm. 2003. Efficiency of a pneumococcal opsonophagocytic killing assay improved by multiplexing and by coloring colonies. Clin. Diagn. Lab. Immunol. 10:616-621.
13. Lin, J. S., M. K. Park, and M. H. Nahm. 2001. Chromogenic assay measuring opsonophagocytic killing capacities of antipneumococcal antisera. Clin. Diagn. Lab. Immunol. 8:528-533.
14. Martinez, J. E., S. Romero-Steiner, T. Pilishivili, S. Barnard, J. Schinsky, D. Goldblatt, and G. Carlone. 1999. A flow cytometric opsonophagocytic assay for measurement of functional antibodies elicited after vaccination with the 23-valent pneumococcal polysaccharide vaccine. Clin. Diagn. Lab. Immunol. 6:581-586.
15. Mountzouros, K. T., and A. P. Howell. 2000. Detection of complement-mediated antibody-dependent bactericidal activity in a fluorescence-based serum bactericidal assay for group B Neisseria meningitidis. J. Clin. Microbiol. 38:2878-2884.
16. Mulholland, K. 1999. Strategies for the control of pneumococcal diseases. Vaccine 17:S79-S84.
17. Obaro, S., and R. Adegbola. 2002. The pneumococcus: carriage, disease and conjugate vaccines. J. Med. Microbiol. 51:98-104.
18. Romero-Steiner, S., D. Libutti, L. B. Pais, J. Dykes, P. Anderson, J. C. Whitin, H. L. Keyserling, and G. M. Carlone. 1997. Standardization of an opsonophagocytic assay for the measurement of functional antibody activity against Streptococcus pneumoniae using differentiated HL-60 cells. Clin. Diagn. Lab. Immunol. 4:415-422.
19. Romero-Steiner, S., C. Frasch, N. Concepcion, D. Goldblatt, H. Käyhty, M. Väkeväinen, C. Laferriere, D. Wauters, M. H. Nahm, M. F. Schinsky, B. D. Plikaytis, and G. M. Carlone. 2003. Multilaboratory evaluation of a viability assay for measurement of opsonophagocytic antibodies specific to the capsular polysaccharides of Streptococcus pneumoniae. Clin. Diagn. Lab. Immunol. 10:1019-1024.
20. Romero-Steiner, S., W. Spear, N. Brown, P. Holder, T. Hennessy, P. Gomez de Leon, and G. Carlone. 2004. Measurement of serum bactericidal activity specific for Haemophilus influenzae type b by using a chromogenic and fluorescent metabolic indicator. Clin. Diagn. Lab. Immunol. 11:89-93.